Findings showed 30% of patients taking linaclotide 145mcg achieved the primary endpoint of combined responder. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the ...

It can be uncomfortable to talk about IBS, but doing so can help you find support and feel less alone. Deciding who to tell and how much to share can help get the conversation started. Irritable bowel ...

For millions of Americans, bathroom trips bring anxiety rather than relief. Irritable bowel syndrome with constipation (IBS-C) impacts approximately one-third of all IBS cases, causing physical ...

How Fiber Works in Your Body How Fiber Helps IBS-C What About FODMAPs? Fiber Supplements Best Fiber-Filled Foods Fiber is a must for regular bowel movements. But if you have irritable bowel syndrome ...

Dear Dr. Roach: I'm a young adult male who has been diagnosed with irritable bowel syndrome with constipation (IBS-C). Until this diagnosis, I had never even heard of the condition. A colonoscopy and ...

Dear Dr. Roach: I’m a young adult male who has been diagnosed with irritable bowel syndrome with constipation (IBS-C). Until this diagnosis, I had never even heard of the condition. A colonoscopy and ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a global GI-focused healthcare company, presented new data from four scientific abstracts during the American College of ...

How do you help patients with soft stool that won't move through manage idiopathic constipation? Join Drs Lin Chang and Anthony Lembo as they discuss nuanced decision-making around treating IBS ...

At the American College of Gastroenterology annual meeting, researchers presented pooled data from two phase III trials to look closer at the effect of plecanatide (Trulance) on severe abdominal pain ...

Ardelyx will leverage the LPGA’s predominantly female audience to directly reach the demographic most affected by IBS-C. The 360-degree approach aims to de-stigmatize chronic gastrointestinal issues ...

Salix Pharmaceuticals has identified a blockage in the irritable bowel syndrome (IBS) care pathway. Based on an online survey of 724 people, the manufacturer of a pair of IBS treatments thinks more ...

Irritable bowel syndrome, or IBS, is among the most common gastrointestinal conditions today. It affects some 10% to 15% of people in the U.S., per the American College of Gastroenterology. A chronic ...